Table 2.
Patient Demographics and Clinical Characteristics
| Demographics | Data, Percentage and/or Number | ||
|---|---|---|---|
| Age, median in years (range) | 62 (20–94) | ||
| Men (%, n) | 68%, 55 | ||
| Underlying Conditions | |||
| Malignancy (%, n) | 33%, 27 | ||
| Esophageal (n) | 14 | ||
| Pancreas (n) | 4 | ||
| Hepatobiliary (n) | 2 | ||
| GI (stomach, colon) (n) | 3 | ||
| Lung (n) | 1 | ||
| Others (prostate, skin glioblastoma) (n) | 3 | ||
| Solid Organ Transplantation (%, n) | 14%, 11 | ||
| Lung (n) | 4 | ||
| Liver (n) | 4 | ||
| Kidney (n) | 2 | ||
| Heart (n) | 1 | ||
| Diabetes Mellitus (%, n) | 22%, 18 | ||
| Cirrhosis (%, n) | 9%, 7 | ||
| Neutropenia (%, n) | 2%, 2 | ||
| Hemodialysis (%, n) | 2%, 2 | ||
| Surgery or Invasive Procedure Within 90 Days (%, n) | 65%, 53 | ||
| Thoracic surgery/procedure (n) | 31 | ||
| Abdominal surgery/procedure (n) | 13 | ||
| Both thoracic and abdominal surgery (n) | 6 | ||
| Other surgeries (orthopedics, brain) (n) | 3 | ||
| Severity of Illness at the Time of Empyema Diagnosis | |||
| Septic shock (%, n) | 41%, 33 | ||
| SAPS II, at time of diagnosis (median, range) | 32 (12–72) | ||
| ICU within 3 days of diagnosis (%, n) | 84% (68) | ||
| Hospital-acquired Candida empyema (%, n) | 65%, 53 |
Abbreviations: GI, gastrointestinal; ICU, intensive care unit; SAPS II, simplified acute physiology score II.
The expected in-hospital mortality rate for SAPS II of 32 is 12.8%.